Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.0B |
| FY2017, ended Dec 31, 2017 | $16.2B |
| FY2018, ended Dec 31, 2018 | $19.2B |
| FY2019, ended Dec 31, 2019 | $24.6B |
| FY2020, ended Dec 31, 2020 | $23.2B |
| FY2021, ended Dec 31, 2021 | $42.3B |
| FY2022, ended Dec 31, 2022 | $41.9B |
| FY2023, ended Dec 31, 2023 | $49.4B |
| FY2024, ended Dec 31, 2024 | $47.6B |
| FY2025, ended Dec 31, 2025 | $52.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $58.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.10B |
| FY2017, ended Dec 31, 2017 | $1.22B |
| FY2018, ended Dec 31, 2018 | $1.33B |
| FY2019, ended Dec 31, 2019 | $1.49B |
| FY2020, ended Dec 31, 2020 | $1.65B |
| FY2021, ended Dec 31, 2021 | $2.08B |
| FY2022, ended Dec 31, 2022 | $3.34B |
| FY2023, ended Dec 31, 2023 | $4.08B |
| FY2024, ended Dec 31, 2024 | $5.27B |
| FY2025, ended Dec 31, 2025 | $5.75B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.05B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $316M | $786M |
| FY2017, ended Dec 31, 2017 | $319M | $861M |
| FY2018, ended Dec 31, 2018 | $364M | $915M |
| FY2019, ended Dec 31, 2019 | $436M | $1.05B |
| FY2020, ended Dec 31, 2020 | $395M | $1.11B |
| FY2021, ended Dec 31, 2021 | $359M | $1.30B |
| FY2022, ended Dec 31, 2022 | $869M | $2.47B |
| FY2023, ended Dec 31, 2023 | $872M | $2.89B |
| FY2024, ended Dec 31, 2024 | $861M | $3.45B |
| FY2025, ended Dec 31, 2025 | $1.06B | $3.86B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.27B | $4.00B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.42M |
| FY2017, ended Dec 31, 2017 | $6.90M |
| FY2018, ended Dec 31, 2018 | $10.4M |
| FY2019, ended Dec 31, 2019 | $54.0M |
| FY2020, ended Dec 31, 2020 | $824M |
| FY2021, ended Dec 31, 2021 | $259M |
| FY2022, ended Dec 31, 2022 | $171M |
| FY2023, ended Dec 31, 2023 | $233M |
| FY2024, ended Dec 31, 2024 | $445M |
| FY2025, ended Dec 31, 2025 | $435M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $553M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.98B |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $901M |
| FY2022, ended Dec 31, 2022 | $702M |
| FY2023, ended Dec 31, 2023 | $764M |
| FY2024, ended Dec 31, 2024 | $67.3M |
| FY2025, ended Dec 31, 2025 | $517M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.40B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 264% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 260M |
| FY2017, ended Dec 31, 2017 | 284M |
| FY2018, ended Dec 31, 2018 | 304M |
| FY2019, ended Dec 31, 2019 | 334M |
| FY2020, ended Dec 31, 2020 | 373M |
| FY2021, ended Dec 31, 2021 | 591M |
| FY2022, ended Dec 31, 2022 | 661M |
| FY2023, ended Dec 31, 2023 | 861M |
| FY2024, ended Dec 31, 2024 | 892M |
| FY2025, ended Dec 31, 2025 | 932M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 946M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $12.0M | $384M | — |
| FY2017, ended Dec 31, 2017 | $13.9M | $705M | — |
| FY2018, ended Dec 31, 2018 | $27.3M | $0 | — |
| FY2019, ended Dec 31, 2019 | $13.7M | $845M | — |
| FY2020, ended Dec 31, 2020 | $16.5M | $1.82B | — |
| FY2021, ended Dec 31, 2021 | $41.8M | $4.44B | $11.6B |
| FY2022, ended Dec 31, 2022 | $21.6M | $4.56B | — |
| FY2023, ended Dec 31, 2023 | $26.2M | $5.44B | — |
| FY2024, ended Dec 31, 2024 | $57.5M | $1.74B | $6.04B |
| FY2025, ended Dec 31, 2025 | $30.8M | $2.36B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $37.4M | $1.94B | — |
Valuation
At current price- Market Cap
- $53.8B
- P/E
- 42.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 8.9×
- Price / Book
- 1.4×
- EV / EBITDA
- 14.5×
Growth
Trailing 12 months- Revenue (TTM)
- $6.05B
- Revenue Growth YoY
- 10.9%
- Revenue CAGR 3Y
- 19.8%
- Revenue CAGR 5Y
- 28.4%
- EPS Growth YoY
- 33.0%
- Net Income Growth YoY
- 38.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 20.1%
- Net Margin
- 20.9%
- FCF Margin
- 66.1%
- Return on Equity
- 3.2%
Earnings
Trailing 12 months- Net Income
- $1.27B
- EPS (diluted)
- $1.37
- EBITDA
- $3.76B
- Operating Income
- $1.22B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $553M
- Total Debt
- $1.40B
- Net Debt
- $847M
- Total Assets
- $76.4B
- Total Liabilities
- $34.5B
- Shareholders' Equity
- $39.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.17B
- Capital Expenditure
- $166M
- Free Cash Flow
- $4.00B
Dividends and risk
Last 12 months- Dividend Yield
- 5.7%
- Dividend / Share
- $3.25
- Beta (5Y)
- 0.69
Every ratio is calculated from the company’s reported figures.